RankAlpha logo
Back to Rankings

ICLR

ICONC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
12
U.S. public peers
Grade Position
In line
vs peer average
ICLR vs peer average
51/100
ICLR vs. peer average (C vs. C)
Grade spread
B 2 · C 8 · D 1 · F 1
Graded peers loaded
Coverage
12 graded
100% of tracked

Peer overview

IQV is the first available peer comparator.

IQVIA is a direct large-scale CRO competitor for global development programs; ICON's 2024 Form 20-F identifies IQVIA among the primary competitors for large development programs, making IQV a cleaner operating comp than drug-developer peers for backlog, bookings, pricing, and trial execution read-through [#20F-2024].

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIQVIQVIA
ICLR
ICON
IQV
IQVIA
Grade
C
C
Momentum
81
51
Value
67
66
Sentiment
9
36
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs IQV

ICLR / IQV
Grade Position
In line
ICLR vs. peer average (C vs. C)
51/100
Momentum
81
ICLR
Value
67
ICLR
Sentiment
9
IQV

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ICLR
1
IQV
IQV
C
60/100
Even
2
FTRE
FTRE
B
80/100
-1
3
MEDP
MEDP
C
60/100
Even
4
TMO
TMO
B
80/100
-1
5
ELAN
Elanco Animal Health Inc Common
C
60/100
Even
IQV is the first peer returned for this comparison set.